Lectin-like Oxidized Low-Density Lipoprotein (LDL) Receptor (LOX-1): A Chameleon Receptor for Oxidized LDL

被引:37
作者
Zeya, Bushra [1 ]
Arjuman, Albina [2 ]
Chandra, Nimai Chand [1 ]
机构
[1] All India Inst Med Sci, Dept Biochem, Patna 801507, Bihar, India
[2] Indian Council Med Res, Div P&I, New Delhi 110029, India
关键词
SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; ENDOTHELIAL-CELLS; NITRIC-OXIDE; OX-LDL; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ADHESION MOLECULES; MURINE MACROPHAGES; SCAVENGER RECEPTOR;
D O I
10.1021/acs.biochem.6b00469
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
LOX-1, one of the main receptors for oxLDL, is found mainly on the surface of endothelial cells. It is a multifacet 52 kDa type II transmembrane protein that structurally belongs to the C-type lectin family. It exists with short intracellular N-terminal and long extracellular C-terminal hydrophilic domains separated by a hydrophobic domain of 26 amino acids. LOX-1 acts like a bifunctional receptor either showing pro-atherogenicity by activating the NF kappa B-mediated down signaling cascade for gene activation of pro-inflammatory molecules or playing an atheroprotective agent by receptor mediated uptake of oxLDL in the presence of an anti-inflammatory molecule like IL-10. Mildly, moderately, and highly oxidized LDL show their characteristic features upon LOX-1 activation and its ligand binding indenture. The polymorphic LOX-1 genes are intensively associated with increased susceptibility to myocardial diseases. The splicing variant LOX IN dimerizes with the native form of LOX-1 and protects cells from damage by oxidized LDL. In the developing field of regenerating medicine, LOX-1 is a potential target for therapeutic intervention.
引用
收藏
页码:4437 / 4444
页数:8
相关论文
共 80 条
[1]   LOX-1 Is a Novel Therapeutic Target in Neonatal Hypoxic-Ischemic Encephalopathy [J].
Akamatsu, Tomohisa ;
Dai, Hongmei ;
Mizuguchi, Masashi ;
Goto, Yu-ichi ;
Oka, Akira ;
Itoh, Masayuki .
AMERICAN JOURNAL OF PATHOLOGY, 2014, 184 (06) :1843-1852
[2]   LOX-1 Inhibition in ApoE KO Mice Using a Schizophyllan-based Antisense Oligonucleotide Therapy [J].
Amati, Francesca ;
Diano, Laura ;
Vecchione, Lucia ;
Norata, Giuseppe Danilo ;
Koyama, Yoshikazu ;
Cutuli, Lucia ;
Catapano, Alberico Luigi ;
Romeo, Francesco ;
Ando, Hironori ;
Novelli, Giuseppe .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2012, 1
[3]   Inflammation-induced foam cell formation in chronic inflammatory disease [J].
Angelovich, Thomas A. ;
Hearps, Anna C. ;
Jaworowski, Anthony .
IMMUNOLOGY AND CELL BIOLOGY, 2015, 93 (08) :683-693
[4]  
[Anonymous], 2015, Disclosed and Protected by Indian Patent Application, Patent No. [1035/DEL/2015, 1035]
[5]   Induction of heme oxygenase 1 by moderately oxidized low-density lipoproteins in human vascular smooth muscle cells: Role of mitogen-activated protein kinases and Nrf2 [J].
Anwar, AA ;
Li, FYL ;
Leake, DS ;
Ishii, T ;
Mann, GE ;
Siow, RCM .
FREE RADICAL BIOLOGY AND MEDICINE, 2005, 39 (02) :227-236
[6]   Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene [J].
Aoyama, T ;
Sawamura, T ;
Furutani, Y ;
Matsuoka, R ;
Yoshida, MC ;
Fujiwara, H ;
Masaki, T .
BIOCHEMICAL JOURNAL, 1999, 339 :177-184
[7]   Differential pro-inflammatory responses of TNF-α receptors (TNFR1 and TNFR2) on LOX-1 signalling [J].
Arjuman, Albina ;
Chandra, Nimai C. .
MOLECULAR BIOLOGY REPORTS, 2015, 42 (06) :1039-1047
[8]   Effect of IL-10 on LOX-1 expression, signalling and functional activity: An atheroprotective response [J].
Arjuman, Albina ;
Chandra, Nimai C. .
DIABETES & VASCULAR DISEASE RESEARCH, 2013, 10 (05) :442-451
[9]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[10]   The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization [J].
Biocca, Silvia ;
Filesi, Ilaria ;
Mango, Ruggiero ;
Maggiore, Luana ;
Baldini, Francesco ;
Vecchione, Lucia ;
Viola, Antonella ;
Citro, Gennaro ;
Federici, Giorgio ;
Romeo, Francesco ;
Novelli, Giuseppe .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 44 (03) :561-570